{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:25:02Z","timestamp":1793381102068,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-02606-3","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T02:25:05Z","timestamp":1745893505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Intelligent predictive risk assessment and management of sarcopenia in chronic disease patients using machine learning and a web-based tool"],"prefix":"10.1186","volume":"30","author":[{"given":"Ke","family":"Rong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu li jiang","family":"Yi ke ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"2606_CR1","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/ehf2.13255","volume":"8","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Zhang J, Ni W, Yuan X, Zhang H, Li P, et al. Sarcopenia in heart failure: a systematic review and meta-analysis. ESC Heart Fail. 2021;8:1007\u201317.","journal-title":"ESC Heart Fail"},{"key":"2606_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/jdi.12392","volume":"7","author":"BK Koo","year":"2016","unstructured":"Koo BK, Roh E, Yang YS, Moon MK. Difference between old and young adults in contribution of \u03b2-cell function and sarcopenia in developing diabetes mellitus. J Diabetes Investig. 2016;7:233\u201340.","journal-title":"J Diabetes Investig"},{"key":"2606_CR3","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jcsm.13425","volume":"15","author":"MP Duarte","year":"2024","unstructured":"Duarte MP, Almeida LS, Neri SGR, Oliveira JS, Wilkinson TJ, Ribeiro HS, et al. Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2024;15:501\u201312.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2606_CR4","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/liv.13730","volume":"38","author":"N Gua\u00f1abens","year":"2018","unstructured":"Gua\u00f1abens N, Par\u00e9s A. Osteoporosis in chronic liver disease. Liver Int. 2018;38:776\u201385.","journal-title":"Liver Int"},{"key":"2606_CR5","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/jcsm.12600","volume":"11","author":"W Sep\u00falveda-Loyola","year":"2020","unstructured":"Sep\u00falveda-Loyola W, Osadnik C, Phu S, Morita AA, Duque G, Probst VS. Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2020;11:1164\u201376.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2606_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.maturitas.2016.11.006","volume":"96","author":"G Bano","year":"2017","unstructured":"Bano G, Trevisan C, Carraro S, Solmi M, Luchini C, Stubbs B, et al. Inflammation and sarcopenia: a systematic review and meta-analysis. Maturitas. 2017;96:10\u20135.","journal-title":"Maturitas"},{"key":"2606_CR7","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1159\/000520096","volume":"68","author":"N Buchmann","year":"2022","unstructured":"Buchmann N, Fielitz J, Spira D, K\u00f6nig M, Norman K, Pawelec G, et al. Muscle mass and inflammation in older adults: impact of the metabolic syndrome. Gerontology. 2022;68:989\u201398.","journal-title":"Gerontology"},{"key":"2606_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.921399","volume":"9","author":"J Gao","year":"2022","unstructured":"Gao J, Deng M, Li Y, Yin Y, Zhou X, Zhang Q, et al. Resistin as a systemic inflammation-related biomarker for sarcopenia in patients with chronic obstructive pulmonary disease. Front Nutr. 2022;9: 921399.","journal-title":"Front Nutr"},{"key":"2606_CR9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.23736\/S1121-421X.18.02511-4","volume":"64","author":"R de Sire","year":"2018","unstructured":"de Sire R, Rizzatti G, Ingravalle F, Pizzoferrato M, Petito V, Lopetuso L, et al. Skeletal muscle-gut axis: emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases. Minerva Gastroenterol Dietol. 2018;64:351\u201362.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"2606_CR10","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.3390\/cells12182257","volume":"12","author":"H-J Oh","year":"2023","unstructured":"Oh H-J, Jin H, Lee J-Y, Lee B-Y. Silk peptide ameliorates sarcopenia through the regulation of Akt\/mTOR\/FoxO3a signaling pathways and the inhibition of low-grade chronic inflammation in aged mice. Cells. 2023;12:2257.","journal-title":"Cells"},{"key":"2606_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102267","volume":"96","author":"G Livshits","year":"2024","unstructured":"Livshits G, Kalinkovich A. Restoration of epigenetic impairment in the skeletal muscle and chronic inflammation resolution as a therapeutic approach in sarcopenia. Ageing Res Rev. 2024;96: 102267.","journal-title":"Ageing Res Rev"},{"key":"2606_CR12","doi-asserted-by":"publisher","first-page":"1264205","DOI":"10.3389\/fmed.2023.1264205","volume":"10","author":"J Xu","year":"2023","unstructured":"Xu J, Pan Y, Zhang J, Dai S, Xu L. Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota. Front Med (Lausanne). 2023;10:1264205.","journal-title":"Front Med (Lausanne)"},{"key":"2606_CR13","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/cells11071078","volume":"11","author":"H Jin","year":"2022","unstructured":"Jin H, Xie W, He M, Li H, Xiao W, Li Y. Pyroptosis and sarcopenia: frontier perspective of disease mechanism. Cells. 2022;11:1078.","journal-title":"Cells"},{"key":"2606_CR14","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.3390\/biom11091327","volume":"11","author":"S Haberecht-M\u00fcller","year":"2021","unstructured":"Haberecht-M\u00fcller S, Kr\u00fcger E, Fielitz J. Out of control: the role of the ubiquitin proteasome system in skeletal muscle during inflammation. Biomolecules. 2021;11:1327.","journal-title":"Biomolecules"},{"key":"2606_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2021.4989","volume":"48","author":"H Nishikawa","year":"2021","unstructured":"Nishikawa H, Fukunishi S, Asai A, Yokohama K, Nishiguchi S, Higuchi K. Pathophysiology and mechanisms of primary sarcopenia (Review). Int J Mol Med. 2021;48:1\u20138.","journal-title":"Int J Mol Med"},{"key":"2606_CR16","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.3390\/ijms22052604","volume":"22","author":"YJ Yang","year":"2021","unstructured":"Yang YJ, Kim DJ. An overview of the molecular mechanisms contributing to musculoskeletal disorders in chronic liver disease: osteoporosis, sarcopenia, and osteoporotic sarcopenia. Int J Mol Sci. 2021;22:2604.","journal-title":"Int J Mol Sci"},{"key":"2606_CR17","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/jcsm.13221","volume":"14","author":"X Zuo","year":"2023","unstructured":"Zuo X, Li X, Tang K, Zhao R, Wu M, Wang Y, et al. Sarcopenia and cardiovascular diseases: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2023;14:1183\u201398.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2606_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12877-023-03784-7","volume":"23","author":"X Zhao","year":"2023","unstructured":"Zhao X, Su R, Hu R, Chen Y, Xu X, Yuan Y, et al. Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study. BMC Geriatr. 2023;23:89.","journal-title":"BMC Geriatr"},{"key":"2606_CR19","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1002\/jcsm.13567","volume":"15","author":"W-H Hsu","year":"2024","unstructured":"Hsu W-H, Wang S-Y, Chao Y-M, Chang K-V, Han D-S, Lin Y-L. Novel metabolic and lipidomic biomarkers of sarcopenia. J Cachexia Sarcopenia Muscle. 2024;15:2175\u201386.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2606_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s13054-024-05138-0","volume":"28","author":"C Guan","year":"2024","unstructured":"Guan C, Gong A, Zhao Y, Yin C, Geng L, Liu L, et al. Interpretable machine learning model for new-onset atrial fibrillation prediction in critically ill patients: a multi-center study. Crit Care. 2024;28:349.","journal-title":"Crit Care"},{"key":"2606_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s43856-022-00180-x","volume":"2","author":"W Qiu","year":"2022","unstructured":"Qiu W, Chen H, Dincer AB, Lundberg S, Kaeberlein M, Lee S-I. Interpretable machine learning prediction of all-cause mortality. Commun Med (Lond). 2022;2:125.","journal-title":"Commun Med (Lond)"},{"key":"2606_CR22","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.clnu.2024.02.002","volume":"43","author":"M Jiang","year":"2024","unstructured":"Jiang M, Ren X, Han L, Zheng X. Associations between sarcopenic obesity and risk of cardiovascular disease: a population-based cohort study among middle-aged and older adults using the CHARLS. Clin Nutr. 2024;43:796\u2013802.","journal-title":"Clin Nutr"},{"key":"2606_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jad.2023.10.012","volume":"344","author":"Y Liu","year":"2024","unstructured":"Liu Y, Cui J, Cao L, Stubbendorff A, Zhang S. Association of depression with incident sarcopenia and modified effect from healthy lifestyle: the first longitudinal evidence from the CHARLS. J Affect Disord. 2024;344:373\u20139.","journal-title":"J Affect Disord"},{"key":"2606_CR24","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","volume":"21","author":"L-K Chen","year":"2020","unstructured":"Chen L-K, Woo J, Assantachai P, Auyeung T-W, Chou M-Y, Iijima K, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21:300-307.e2.","journal-title":"J Am Med Dir Assoc"},{"key":"2606_CR25","doi-asserted-by":"publisher","first-page":"1416796","DOI":"10.3389\/fpubh.2024.1416796","volume":"12","author":"S Zhou","year":"2024","unstructured":"Zhou S, Liu Y, Zhang Y, Luo N, Chen Q, Ge M, et al. Association between persistent musculoskeletal pain and incident sarcopenia in China: the mediating effect of depressive symptoms. Front Public Health. 2024;12:1416796.","journal-title":"Front Public Health"},{"key":"2606_CR26","first-page":"551","volume":"20","author":"X Wen","year":"2011","unstructured":"Wen X, Wang M, Jiang C-M, Zhang Y-M. Anthropometric equation for estimation of appendicular skeletal muscle mass in Chinese adults. Asia Pac J Clin Nutr. 2011;20:551\u20136.","journal-title":"Asia Pac J Clin Nutr"},{"key":"2606_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12933-024-02334-8","volume":"23","author":"M Duan","year":"2024","unstructured":"Duan M, Zhao X, Li S, Miao G, Bai L, Zhang Q, et al. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2024;23:243.","journal-title":"Cardiovasc Diabetol"},{"key":"2606_CR28","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12933-024-02354-4","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang F, Tang J, Shen L, He J, Chen Y. Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999\u20132018. Cardiovasc Diabetol. 2024;23:262.","journal-title":"Cardiovasc Diabetol"},{"key":"2606_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1023\/A:1012487302797","volume":"46","author":"I Guyon","year":"2002","unstructured":"Guyon I, Weston J, Barnhill S, Vapnik V. Gene selection for cancer classification using support vector machines. Mach Learn. 2002;46:389\u2013422.","journal-title":"Mach Learn"},{"key":"2606_CR30","doi-asserted-by":"crossref","unstructured":"Wei H-L, Billings SA. Modeling COVID-19 Pandemic Dynamics Using Transparent, Interpretable, Parsimonious and Simulatable (TIPS) Machine Learning Models: A Case Study from Systems Thinking and System Identification Perspectives. In: Recent Advances in AI-enabled Automated Medical Diagnosis. CRC Press; 2022.","DOI":"10.1101\/2021.11.01.21265653"},{"key":"2606_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2023.100320","volume":"104","author":"F Deng","year":"2024","unstructured":"Deng F, Zhao L, Yu N, Lin Y, Zhang L. Union With Recursive Feature Elimination: A Feature Selection Framework to Improve the Classification Performance of Multicategory Causes of Death in Colorectal Cancer. Lab Invest. 2024;104: 100320.","journal-title":"Lab Invest"},{"key":"2606_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780198524847.001.0001","volume-title":"Analysis of Longitudinal Data","author":"PJ Diggle","year":"2002","unstructured":"Diggle PJ, Heagerty P, Liang KY, Zeger SL. Analysis of Longitudinal Data. 2nd ed. Oxford: Oxford University Press; 2002.","edition":"2"},{"key":"2606_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-074819","volume":"384","author":"GS Collins","year":"2024","unstructured":"Collins GS, Dhiman P, Ma J, Schlussel MM, Archer L, Van Calster B, et al. Evaluation of clinical prediction models (part 1): from development to external validation. BMJ. 2024;384: e074819.","journal-title":"BMJ"},{"key":"2606_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12569","volume":"23","author":"T Hosoi","year":"2024","unstructured":"Hosoi T, Yakabe M, Hashimoto S, Akishita M, Ogawa S. The roles of sex hormones in the pathophysiology of age-related sarcopenia and frailty. Reprod Med Biol. 2024;23: e12569.","journal-title":"Reprod Med Biol"},{"key":"2606_CR35","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1002\/jcsm.13627","volume":"15","author":"L Yin","year":"2024","unstructured":"Yin L, Zhao J. An Artificial Intelligence Approach for Test-Free Identification of Sarcopenia. J Cachexia Sarcopenia Muscle. 2024;15:2765\u201380.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2606_CR36","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3390\/healthcare11091334","volume":"11","author":"M Seok","year":"2023","unstructured":"Seok M, Kim W. Sarcopenia Prediction for Elderly People Using Machine Learning: A Case Study on Physical Activity. Healthcare. 2023;11:1334.","journal-title":"Healthcare"},{"key":"2606_CR37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/ggi.14895","volume":"24","author":"J Kim","year":"2024","unstructured":"Kim J. Machine-learning classifier models for predicting sarcopenia in the elderly based on physical factors. Geriatr Gerontol Int. 2024;24:595\u2013602.","journal-title":"Geriatr Gerontol Int"},{"key":"2606_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2024.112631","volume":"198","author":"G Zhang","year":"2024","unstructured":"Zhang G, Fu J, Zhang H, Xu X, Cao Z. The impact of Life\u2019s Essentials 8 on sarcopenia prevalence among adults in the United States. Exp Gerontol. 2024;198: 112631.","journal-title":"Exp Gerontol"},{"key":"2606_CR39","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1186\/s12877-024-05528-7","volume":"24","author":"W-S Lin","year":"2024","unstructured":"Lin W-S, Hsu N-W, Yang S-H, Chen Y-T, Tsai C-C, Pan P-J. Predicting sarcopenia in community-dwelling older adults through comprehensive physical fitness tests. BMC Geriatr. 2024;24:932.","journal-title":"BMC Geriatr"},{"key":"2606_CR40","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1053\/j.jrn.2023.01.012","volume":"33","author":"LN Shah","year":"2023","unstructured":"Shah LN, Leonard MB, Ziolkowski SL, Grimm P, Long J. Cystatin C and Creatinine Concentrations Are Uninformative Biomarkers of Sarcopenia: A Cross-Sectional NHANES Study. J Ren Nutr. 2023;33:538\u201345.","journal-title":"J Ren Nutr"},{"key":"2606_CR41","doi-asserted-by":"publisher","first-page":"116","DOI":"10.14283\/jfa.2024.13","volume":"13","author":"R Matsuzawa","year":"2024","unstructured":"Matsuzawa R, Nagai K, Takahashi K, Mori T, Onishi M, Tsuji S, et al. Serum Creatinine-Cystatin C Based Screening of Sarcopenia in Community Dwelling Older Adults: A Cross-Sectional Analysis. J Frailty Aging. 2024;13:116\u201324.","journal-title":"J Frailty Aging"},{"key":"2606_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12877-022-02817-x","volume":"22","author":"X Liu","year":"2022","unstructured":"Liu X, Chen X, Hu F, Xia X, Hou L, Zhang G, et al. Higher uric acid serum levels are associated with sarcopenia in west China: a cross-sectional study. BMC Geriatr. 2022;22:121.","journal-title":"BMC Geriatr"},{"key":"2606_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2022.111960","volume":"169","author":"H Gao","year":"2022","unstructured":"Gao H, Wang J, Zou X, Zhang K, Zhou J, Chen M. High blood urea nitrogen to creatinine ratio is associated with increased risk of sarcopenia in patients with chronic obstructive pulmonary disease. Exp Gerontol. 2022;169: 111960.","journal-title":"Exp Gerontol"},{"key":"2606_CR44","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1093\/ckj\/sfad086","volume":"16","author":"L Malmgren","year":"2023","unstructured":"Malmgren L, Grubb A. Muscle mass, creatinine, cystatin C and selective glomerular hypofiltration syndromes. Clin Kidney J. 2023;16:1206\u201310.","journal-title":"Clin Kidney J"},{"key":"2606_CR45","doi-asserted-by":"publisher","first-page":"580","DOI":"10.23876\/j.krcp.21.214","volume":"41","author":"JN An","year":"2022","unstructured":"An JN, Kim J-K, Lee H-S, Kim SG, Kim HJ, Song YR. Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease. Kidney Res Clin Pract. 2022;41:580\u201390.","journal-title":"Kidney Res Clin Pract"},{"key":"2606_CR46","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1016\/j.clnu.2020.12.043","volume":"40","author":"PC Nahas","year":"2021","unstructured":"Nahas PC, Rossato LT, de Branco FMS, Azeredo CM, Rinaldi AEM, de Oliveira EP. Serum uric acid is positively associated with muscle strength in older men and women: Findings from NHANES 1999\u20132002. Clin Nutr. 2021;40:4386\u201393.","journal-title":"Clin Nutr"},{"key":"2606_CR47","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.3390\/nu12082390","volume":"12","author":"JP Floriano","year":"2020","unstructured":"Floriano JP, Nahas PC, de Branco FMS, Dos Reis AS, Rossato LT, Santos HO, et al. Serum Uric Acid Is Positively Associated with Muscle Mass and Strength, but Not with Functional Capacity, in Kidney Transplant Patients. Nutrients. 2020;12:2390.","journal-title":"Nutrients"},{"key":"2606_CR48","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrneph.2014.112","volume":"10","author":"XH Wang","year":"2014","unstructured":"Wang XH, Mitch WE. Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol. 2014;10:504\u201316.","journal-title":"Nat Rev Nephrol"},{"key":"2606_CR49","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1097\/01.ASN.0000034910.58454.FD","volume":"13","author":"D-H Kang","year":"2002","unstructured":"Kang D-H, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002;13:2888\u201397.","journal-title":"J Am Soc Nephrol"},{"key":"2606_CR50","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s12603-023-2029-3","volume":"27","author":"M Kitago","year":"2023","unstructured":"Kitago M, Seino S, Shinkai S, Nofuji Y, Yokoyama Y, Toshiki H, et al. Cross-Sectional and Longitudinal Associations of Creatinine-to-Cystatin C Ratio with Sarcopenia Parameters in Older Adults. J Nutr Health Aging. 2023;27:946\u201352.","journal-title":"J Nutr Health Aging"},{"key":"2606_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2024.112560","volume":"196","author":"H Huang","year":"2024","unstructured":"Huang H, Yu X, Jiang S, Wang C, Chen Z, Chen D, et al. The relationship between serum lipid with sarcopenia: Results from the NHANES 2011\u20132018 and bidirectional Mendelian randomization study. Exp Gerontol. 2024;196: 112560.","journal-title":"Exp Gerontol"},{"key":"2606_CR52","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1139\/apnm-2015-0350","volume":"40","author":"BJ Shad","year":"2015","unstructured":"Shad BJ, Smeuninx B, Atherton PJ, Breen L. The mechanistic and ergogenic effects of phosphatidic acid in skeletal muscle. Appl Physiol Nutr Metab. 2015;40:1233\u201341.","journal-title":"Appl Physiol Nutr Metab"},{"key":"2606_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101865","volume":"9","author":"R Mahfouz","year":"2014","unstructured":"Mahfouz R, Khoury R, Blachnio-Zabielska A, Turban S, Loiseau N, Lipina C, et al. Characterising the inhibitory actions of ceramide upon insulin signaling in different skeletal muscle cell models: a mechanistic insight. PLoS ONE. 2014;9: e101865.","journal-title":"PLoS ONE"},{"key":"2606_CR54","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/jcsm.12901","volume":"13","author":"C-W Li","year":"2022","unstructured":"Li C-W, Yu K, Shyh-Chang N, Jiang Z, Liu T, Ma S, et al. Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review. J Cachexia Sarcopenia Muscle. 2022;13:781\u201394.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2606_CR55","doi-asserted-by":"crossref","unstructured":"Nur Zati Iwani AK, Jalaludin MY, Yahya A, Mansor F, Md Zain F, Hong JYH, et al. TG: HDL-C Ratio as Insulin Resistance Marker for Metabolic Syndrome in Children With Obesity. Front Endocrinol (Lausanne). 2022;13:852290.","DOI":"10.3389\/fendo.2022.852290"},{"key":"2606_CR56","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s40200-020-00679-x","volume":"19","author":"P Prasun","year":"2020","unstructured":"Prasun P. Role of mitochondria in pathogenesis of type 2 diabetes mellitus. J Diabetes Metab Disord. 2020;19:2017\u201322.","journal-title":"J Diabetes Metab Disord"},{"key":"2606_CR57","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1210\/clinem\/dgab884","volume":"107","author":"L Feng","year":"2022","unstructured":"Feng L, Gao Q, Hu K, Wu M, Wang Z, Chen F, et al. Prevalence and Risk Factors of Sarcopenia in Patients With Diabetes: A Meta-analysis. J Clin Endocrinol Metab. 2022;107:1470\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"2606_CR58","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1002\/jcsm.13025","volume":"13","author":"M Kamiya","year":"2022","unstructured":"Kamiya M, Mizoguchi F, Yasuda S. Amelioration of inflammatory myopathies by glucagon-like peptide-1 receptor agonist via suppressing muscle fibre necroptosis. J Cachexia Sarcopenia Muscle. 2022;13:2118\u201331.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2606_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155585","volume":"144","author":"Y Hashimoto","year":"2023","unstructured":"Hashimoto Y, Takahashi F, Okamura T, Hamaguchi M, Fukui M. Diet, exercise, and pharmacotherapy for sarcopenia in people with diabetes. Metabolism. 2023;144: 155585.","journal-title":"Metabolism"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02606-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T03:03:21Z","timestamp":1745895801000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02606-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2606"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02606-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6161594\/v1","asserted-by":"object"}]},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted via openly available statistics and therefore did not require ethical approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"345"}}